Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Bolt Biotherapeutics, Inc. (BOLT) had Income from Continuous Operations of $-11.04M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$1.22M |
|
$-11.04M |
|
-- |
|
$1.22M |
|
$13.34M |
|
$-12.12M |
|
$1.07M |
|
$-11.04M |
|
$-11.04M |
|
$-11.04M |
|
|
Income from Continuous Operations |
$-11.04M |
$-11.04M |
|
$-11.04M |
|
$-12.12M |
|
$-11.93M |
|
38.34M |
|
38.34M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$42.51M |
|
$2.06M |
|
$43.35M |
|
$85.86M |
|
$13.56M |
|
$22.31M |
|
$25.49M |
|
$39.05M |
|
$46.81M |
|
$46.81M |
|
$46.81M |
|
38.34M |
|
| Cash Flow Statement Financials | |
$-13.37M |
|
$14.55M |
|
-- |
|
$8.97M |
|
$10.16M |
|
$1.19M |
|
$0.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.13 |
|
-- |
|
-- |
|
0.32 |
|
0.48 |
|
100.00% |
|
-991.41% |
|
-991.41% |
|
-- |
|
-903.44% |
|
-903.44% |
|
$-12.40M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-23.58% |
|
-23.58% |
|
-12.86% |
|
-15.97% |
|
$1.22 |
|
$-0.32 |
|
$-0.35 |
|